Literature DB >> 3081249

Effect of dietary polyunsaturated fat and 7,12-dimethylbenz(a)-anthracene on rat splenic natural killer cells and prostaglandin E synthesis.

K H Leung, M M Ip.   

Abstract

Dietary polyunsaturated fat has been shown to stimulate mammary tumorigenesis induced in rats by 7,12-dimethylbenz(a)anthracene (DMBA). Studies were undertaken to investigate the effect of polyunsaturated fat and DMBA on splenic natural killer (NK) activity and prostaglandin E (PGE) synthesis. In a first experiment, splenic NK activity at 33, 55, 75, and 110 days of age was measured in Sprague-Dawley rats fed 0.5% low fat (LF), 5% normal fat (NF), or 20% high fat (HF) corn oil diets from 23 days of age. At 55 days of age, half of the rats from the 75 and 110 day age groups were given 5 mg DMBA. Ten days after the initiation of the diets splenic NK activity against YAC-1 lymphoma was decreased from 50% cytotoxicity in rats fed NF diet to 21% cytotoxicity in rats fed HF diet, but was not affected by LF feeding. No difference in NK activity was observed among the groups at the later time periods. DMBA had no effect on NK activity at 20 or 55 days after its administration. In a second experiment, where DMBA (15 mg/rat) was given to half of the rats at 50 days of age and NF or HF diets were started 3 days later, NK activity was 35% in rats fed NF diet and 21% in rats fed HF diet, 5 days after the diets were started. No difference in NK activity in rats fed either diet was observed at later time periods. DMBA decreased both NK activity and spleen cellularity transiently. In both experiments, PGE synthesis by spleen cells cultured for 18 h was not affected by dietary fat intake, but was slightly increased 3 days after DMBA administration. Results from these experiments suggest that the stimulation of DMBA-induced mammary tumorigenesis by polyunsaturated fat and by DMBA itself may possibly be mediated by a transient decrease in splenic NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081249     DOI: 10.1007/bf00199865

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  20 in total

1.  Inhibition of murine natural killer cell activity by prostaglandins.

Authors:  M J Brunda; R B Herberman; H T Holden
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

2.  A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells.

Authors:  M J Droller; M U Schneider; P Perlmann
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

3.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

Review 4.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

5.  Neoplastic growth of carcinogen-treated mammary transplants as influenced by fat intake of donor and host.

Authors:  C Ip; D Sinha
Journal:  Cancer Lett       Date:  1981-02       Impact factor: 8.679

6.  In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells.

Authors:  M S Kennedy; J D Stobo; M E Goldyne
Journal:  Prostaglandins       Date:  1980-07

7.  Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.

Authors:  K H Leung; H S Koren
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Inhibition of the activity of mouse natural killer cells by urethan.

Authors:  E Gorelik; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

9.  Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells.

Authors:  K H Leung; E Mihich
Journal:  Int J Immunopharmacol       Date:  1982

10.  Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat.

Authors:  C A Carter; R J Milholland; W Shea; M M Ip
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.